Live from the NIH registry
Studies recruiting near Warner Robins right now
Top 25 of 73 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
The Jones Center Clinical Research /ID# 256529 — Macon, Georgia (16.9 mi)
· Sponsor: AbbVie
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Gastroenterology Associates of Central Georgia — Macon, Georgia (16.9 mi)
· Sponsor: Boehringer Ingelheim
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Skin Care Physicians of Georgia - Macon- Site Number : 8400034 — Macon, Georgia (16.9 mi)
· Sponsor: Sanofi
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Atrium Health Navicent — Macon, Georgia (16.9 mi)
· Sponsor: Children's Oncology Group
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
The Jones Center Clinical Research, LLC — Macon, Georgia (16.9 mi)
· Sponsor: vTv Therapeutics
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Crohn's Disease
Phase 2
Interventional 540 participants sought
Gastroenterology Associates of Central Georgia /ID# 265547 — Macon, Georgia (16.9 mi)
· Sponsor: AbbVie
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Gastroenterolgy Associates of Central GA — Macon, Georgia (16.9 mi)
· Sponsor: Janssen Research & Development, LLC
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Moderate-to-Severe Atopic Dermatitis
Phase 3
Interventional 510 participants sought
Nektar Investigative Site — Macon, Georgia (16.9 mi)
· Sponsor: Nektar Therapeutics
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Narcolepsy
Phase 2
Interventional 64 participants sought
Sleep Practitioners, LLC — Macon, Georgia (16.9 mi)
· Sponsor: Eisai Inc.
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Gastroenterology Associates of Central Georgia — Macon, Georgia (16.9 mi)
· Sponsor: Hoffmann-La Roche
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Kidney Disease, Chronic
Phase 3
Interventional 11,000 participants sought
East Coast Institute For Research LLC — Macon, Georgia (16.9 mi)
· Sponsor: Boehringer Ingelheim
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
Phase 3
Interventional 330 participants sought
Central Georgia Cancer Care PC — Macon, Georgia (16.9 mi)
· Sponsor: Amgen
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2, Phase 3
Interventional 256 participants sought
Alkermes Investigational Site — Macon, Georgia (16.9 mi)
· Sponsor: Alkermes, Inc.
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Phase 3
Interventional 2,130 participants sought
Research Site — Macon, Georgia (16.9 mi)
· Sponsor: AstraZeneca
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor
Phase 3
Interventional 1,656 participants sought
Atrium Health Navicent — Macon, Georgia (16.9 mi)
· Sponsor: Children's Oncology Group
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Multiple Myeloma
Phase 2
Interventional 200 participants sought
GSK Investigational Site — Macon, Georgia (16.9 mi)
· Sponsor: GlaxoSmithKline
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 3
Interventional 530 participants sought
Gastroenterology Associates of Central GA — Macon, Georgia (16.9 mi)
· Sponsor: Janssen Research & Development, LLC
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Persistent Atrial Fibrillation
N/A
Interventional 376 participants sought
Atrium Health Navicent The Medical Center — Macon, Georgia (16.9 mi)
· Sponsor: Boston Scientific Corporation
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Phase 2
Interventional 224 participants sought
Novartis Investigative Site — Macon, Georgia (16.9 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Macon, Georgia (16.9 mi)
· Sponsor: AstraZeneca
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
EDS, Cataplexy
Phase 3
Interventional 258 participants sought
Sleep Practitioners, LLC — Macon, Georgia (16.9 mi)
· Sponsor: Harmony Biosciences Management, Inc.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
The Jones Center Clinical Research, LLC — Macon, Georgia (16.9 mi)
· Sponsor: Boehringer Ingelheim
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Skin Care Physicians Of Georgia — Macon, Georgia (16.9 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Gastroenterology Associates of Central Georgia — Macon, Georgia (16.9 mi)
· Sponsor: Hoffmann-La Roche
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Atrium Health Navicent — Macon, Georgia (16.9 mi)
· Sponsor: National Cancer Institute (NCI)